Maturity-onset diabetes of the young (MODY): an update
The DOI matches its Crossref record; 114 of the 118 references it cites were found in a registry or an index.
Abstract
Maturity-onset diabetes of the young (MODY) is a group of monogenic disorders characterized by autosomal dominantly inherited non-insulin dependent form of diabetes classically presenting in adolescence or young adults before the age of 25 years. MODY is a rare cause of diabetes (1% of all cases) and is frequently misdiagnosed as Type 1 diabetes (T1DM) or Type 2 diabetes (T2DM). A precise molecular diagnosis is essential because it leads to optimal treatment of the patients and allows early diagnosis for their asymptomatic family members. Mutations in the glucokinase (GCK) (MODY 2) and hepatocyte nuclear factor (HNF)1A/4A (MODY 3 and MODY 1) genes are the most common causes of MODY. GCK mutations cause a mild, asymptomatic, and stable fasting hyperglycemia usually requiring no specific treatment. However, mutations in the HNF1A and HNF4A cause a progressive pancreatic β-cell dysfunction and hyperglycemia that can result in microvascular complications. Sulfonylureas are effective in these patients by acting on adenosine triphosphate (ATP)-sensitive potassium channels, although insulin therapy may be required later in life. Mutations in the HNF1B (MODY 5) is associated with pancreatic agenesis, renal abnormalities, genital tract malformations, and liver dysfunction. Compared to MODY 1, 2, 3, and 5, the remaining subtypes of MODY have a much lower prevalence. In this review, we summarize the main clinical and laboratory characteristics of the common and rarer causes of MODY.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The risks of microvascular and macrovascular complications with HNF1A-MODY and HNF4AMODY are similar to those observed in people with type 1 and type 2 diabetes (175,176).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [176]
Citations
Cites
Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young
Fajans, S. S., Bell, G. I., & Polonsky, K. S. (2001) · New England Journal of Medicine · doi:10.1056/nejmra002168 · Cited by 1,123 · cited 2×
“The decrease in GCK activity in pancreatic β-cells caused by GCK mutations lead to decreased glucose phosphorylation and glucose sensitivity in β-cells, and a shift in the dose-response relationship between plasma glucose concentrations and insulin secretion to the right (21).”
BackgroundEarly-onset type-ll diabetes mellitus (MODY4) linked to IPF1
Staffers, D. A., Ferrer, J., Clarke, W. L., & Habener, J. F. (1997) · Nature Genetics · doi:10.1038/ng1097-138 · Cited by 882
Mutation in hepatocyte nuclear factor–1β gene (TCF2) associated with MODY
Horikawa, Y., Iwasaki, N., Hara, M., Furuta, H., Hinokio, Y., Cockburn, B. N., Lindner, T., Yamagata, K., Ogata, M., Tomonaga, O., et al. (1997) · Nature Genetics · doi:10.1038/ng1297-384 · Cited by 880
Maturity-onset diabetes of the young (MODY): how many cases are we missing?
Shields, B. M., Hicks, S., Shepherd, M. H., Colclough, K., Hattersley, A. T., & Ellard, S. (2010) · Diabetologia · doi:10.1007/s00125-010-1799-4 · Cited by 725
Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus
Malecki, M. T., Jhala, U. S., Antonellis, A., Fields, L., Doria, A., Orban, T., Saad, M., Warram, J. H., Montminy, M., & Krolewski, A. S. (1999) · Nature Genetics · doi:10.1038/15500 · Cited by 619
Genetic cause of hyperglycaemia and response to treatment in diabetes
Pearson, E. R., Starkey, B. J., Powell, R. J., Gribble, F. M., Clark, P. M., & Hattersley, A. T. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14571-0 · Cited by 607 · cited 4×
“A correct diagnosis and differentiating MODY from T1DM and T2DM are important when deciding on a patient’s treatment and determining his or her prognosis, as well as detecting at-risk family members (31, 82, 83).”
BackgroundInfluentialOsbak, K. K., Colclough, K., Saint-Martin, C., Beer, N. L., Bellanné-Chantelot, C., Ellard, S., & Gloyn, A. L. (2009) · Human Mutation · doi:10.1002/humu.21110 · Cited by 485
Tattersall, R. B., Fajans, S. S., & Arbor, A. (1975) · Diabetes · doi:10.2337/diab.24.1.44 · Cited by 475
Pearson, E. R., Boj, S. F., Steele, A. M., Barrett, T., Stals, K., Shield, J. P., Ellard, S., Ferrer, J., & Hattersley, A. T. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040118 · Cited by 427
Stoffel, M., & Duncan, S. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13209 · Cited by 406
Minireview: Transcriptional Regulation in Pancreatic Development
Habener, J. F., Kemp, D. M., & Thomas, M. K. (2005) · Endocrinology · doi:10.1210/en.2004-1576 · Cited by 399
Pihoker, C., Gilliam, L. K., Ellard, S., Dabelea, D., Davis, C., Dolan, L. M., Greenbaum, C. J., Imperatore, G., Lawrence, J. M., Marcovina, S. M., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1279 · Cited by 397
Insulin Mutation Screening in 1,044 Patients With Diabetes
Edghill, E. L., Flanagan, S. E., Patch, A.-M., Boustred, C., Parrish, A., Shields, B., Shepherd, M. H., Hussain, K., Kapoor, R. R., Malecki, M., et al. (2008) · Diabetes · doi:10.2337/db07-1405 · Cited by 397
Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction
Ræder, H., Johansson, S., Holm, P. I., Haldorsen, I. S., Mas, E., Sbarra, V., Nermoen, I., Eide, S. Å., Grevle, L., Bjørkhaug, L., et al. (2006) · Nature Genetics · doi:10.1038/ng1708 · Cited by 376
Clinical Spectrum Associated with Hepatocyte Nuclear Factor-1β Mutations
Bellanné-Chantelot, C., Chauveau, D., Gautier, J.-F., Dubois-Laforgue, D., Clauin, S., Beaufils, S., Wilhelm, J.-M., Boitard, C., Noël, L.-H., Velho, G., et al. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-7-200404060-00009 · Cited by 358
Mild Familial Diabetes with Dominant Inheritance
(1974) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a067391 · Cited by 354
Mutations in hepatocyte nuclear factor-1β and their related phenotypes
Edghill, E. L., Bingham, C., Ellard, S., & Hattersley, A. T. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2005.032854 · Cited by 344
Shields, B. M., McDonald, T. J., Ellard, S., Campbell, M. J., Hyde, C., & Hattersley, A. T. (2012) · Diabetologia · doi:10.1007/s00125-011-2418-8 · Cited by 335
Fajans, S. S., & Bell, G. I. (2011) · Diabetes Care · doi:10.2337/dc11-0035 · Cited by 320
Eriksson, U., Dahlström, E., Larsson, K. S., & Hellerström, C. (1982) · Diabetes · doi:10.2337/diab.31.1.1 · Cited by 309
Neve, B., Fernandez-Zapico, M. E., Ashkenazi-Katalan, V., Dina, C., Hamid, Y. H., Joly, E., Vaillant, E., Benmezroua, Y., Durand, E., Bakaher, N., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409177102 · Cited by 293
Bingham, C., Bulman, M. P., Ellard, S., Allen, L. I. S., Lipkin, G. W., Hoff, W. G. V., Woolf, A. S., Rizzoni, G., Novelli, G., Nicholls, A. J., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/316945 · Cited by 287
The genetic abnormality in the beta cell determines the response to an oral glucose load
Stride, A., Vaxillaire, M., Tuomi, T., Barbetti, F., Njølstad, P. R., Hansen, T., Costa, A., Conget, I., Pedersen, O., Søvik, O., et al. (2002) · Diabetologia · doi:10.1007/s00125-001-0770-9 · Cited by 277
Maturity-onset diabetes of the young: clinical heterogeneity explained by genetic heterogeneity
Hattersley, A. T. (1998) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(199801)15:1<15::aid-dia562>3.0.co;2-m · Cited by 277
Velho, G., Blanché, H., Vaxillaire, M., Bellanné-Chantelot, C., Pardini, V. C., Timsit, J., Passa, P., Deschamps, I., Robert, J.-J., Weber, I. T., et al. (1997) · Diabetologia · doi:10.1007/s001250050666 · Cited by 266
Renal Phenotypes Related to Hepatocyte Nuclear Factor-1β (TCF2) Mutations in a Pediatric Cohort
Ulinski, T., Lescure, S., Beaufils, S., Guigonis, V., Decramer, S., Morin, D., Clauin, S., Desche[Combining Circumflex Accent]nes, G., Bouissou, F. C., Bensman, A., et al. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005101040 · Cited by 265
The diagnosis and management of monogenic diabetes in children and adolescents
Hattersley, A., Bruining, J., Shield, J., Njolstad, P., & Donaghue, K. C. (2009) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2009.00571.x · Cited by 255
Shepherd, M., Shields, B., Ellard, S., Rubio‐Cabezas, O., & Hattersley, A. T. (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02690.x · Cited by 241
Pearson, E. R., Pruhova, S., Tack, C. J., Johansen, A., Castleden, H. A. J., Lumb, P. J., Wierzbicki, A. S., Clark, P. M., Lebl, J., Pedersen, O., et al. (2005) · Diabetologia · doi:10.1007/s00125-005-1738-y · Cited by 232
Frayling, T. M., Bulman, M. P., Ellard, S., Appleton, M., Dronsfield, M. J., Mackie, A. D. R., Baird, J. D., Kaisaki, P. J., Yamagata, K., Bell, G. I., et al. (1997) · Diabetes · doi:10.2337/diab.46.4.720 · Cited by 231
McDonald, T. J., Colclough, K., Brown, R., Shields, B., Shepherd, M., Bingley, P., Williams, A., Hattersley, A. T., & Ellard, S. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03287.x · Cited by 229
HNF1α controls renal glucose reabsorption in mouse and man
Pontoglio, M., Prié, D., Cheret, C., Doyen, A., Leroy, C., Froguel, P., Velho, G., Yaniv, M., & Friedlander, G. (2000) · EMBO reports · doi:10.1093/embo-reports/kvd071 · Cited by 228
Autoantigens IA-2 and GAD in Type I (insulin-dependent) diabetes
Leslie, R. D. G., Atkinson, M. A., & Notkins, A. L. (1999) · Diabetologia · doi:10.1007/s001250051105 · Cited by 225
Colclough, K., Bellanne-Chantelot, C., Saint-Martin, C., Flanagan, S. E., & Ellard, S. (2013) · Human Mutation · doi:10.1002/humu.22279 · Cited by 224
Stride, A., Shields, B., Gill-Carey, O., Chakera, A. J., Colclough, K., Ellard, S., & Hattersley, A. T. (2014) · Diabetologia · doi:10.1007/s00125-013-3075-x · Cited by 212
Mutations in the Insulin Gene Can Cause MODY and Autoantibody-Negative Type 1 Diabetes
Molven, A., Ringdal, M., Nordbø, A. M., Ræder, H., Støy, J., Lipkind, G. M., Steiner, D. F., Philipson, L. H., Bergmann, I., Aarskog, D., et al. (2008) · Diabetes · doi:10.2337/db07-1467 · Cited by 209
Whole-Exome Sequencing and High Throughput Genotyping Identified KCNJ11 as the Thirteenth MODY Gene
Bonnefond, A., Philippe, J., Durand, E., Dechaume, A., Huyvaert, M., Montagne, L., Marre, M., Balkau, B., Fajardy, I., Vambergue, A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037423 · Cited by 204
Thanabalasingham, G., Pal, A., Selwood, M. P., Dudley, C., Fisher, K., Bingley, P. J., Ellard, S., Farmer, A. J., McCarthy, M. I., & Owen, K. R. (2012) · Diabetes Care · doi:10.2337/dc11-1243 · Cited by 201
Diagnosis and management of maturity onset diabetes of the young (MODY)
Thanabalasingham, G., & Owen, K. R. (2011) · BMJ · doi:10.1136/bmj.d6044 · Cited by 200
Mutations at the BLK locus linked to maturity onset diabetes of the young and β-cell dysfunction
Borowiec, M., Liew, C. W., Thompson, R., Boonyasrisawat, W., Hu, J., Mlynarski, W. M., El Khattabi, I., Kim, S.-H., Marselli, L., Rich, S. S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906474106 · Cited by 189
Schober, E., Rami, B., Grabert, M., Thon, A., Kapellen, T., Reinehr, T., & Holl, R. W. (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02720.x · Cited by 182
Heterozygous ABCC8 mutations are a cause of MODY
Bowman, P., Flanagan, S. E., Edghill, E. L., Damhuis, A., Shepherd, M. H., Paisey, R., Hattersley, A. T., & Ellard, S. (2012) · Diabetologia · doi:10.1007/s00125-011-2319-x · Cited by 177
Wang, J., Elghazi, L., Parker, S. E., Kizilocak, H., Asano, M., Sussel, L., & Sosa‐Pineda, B. (2003) · Developmental Biology · doi:10.1016/j.ydbio.2003.10.018 · Cited by 175
Agenesis of Human Pancreas due to Decreased Half-Life of Insulin Promoter Factor 1
Schwitzgebel, V. M., Mamin, A., Brun, T., Ritz-Laser, B., Zaiko, M., Maret, A., Jornayvaz, F. R., Theintz, G. E., Michielin, O., Melloul, D., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030046 · Cited by 175
Edghill, E. L., Bingham, C., Slingerland, A. S., Minton, J. A. L., Noordam, C., Ellard, S., & Hattersley, A. T. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01999.x · Cited by 174
Al-Zahrani, A., Sandhu, M. S., Luben, R. N., Thompson, D., Baynes, C., Pooley, K. A., Luccarini, C., Munday, H., Perkins, B., Smith, P., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddi398 · Cited by 173
PAX4 Mutations in Thais with Maturity Onset Diabetes of the Young
Plengvidhya, N., Kooptiwut, S., Songtawee, N., Doi, A., Furuta, H., Nishi, M., Nanjo, K., Tantibhedhyangkul, W., Boonyasrisawat, W., Yenchitsomanus, P.-T., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1927 · Cited by 172
Defective Pancreatic β-Cell Glycolytic Signaling in Hepatocyte Nuclear Factor-1α-deficient Mice
Dukes, I. D., Sreenan, S., Roe, M. W., Levisetti, M., Zhou, Y.-P., Ostrega, D., Bell, G. I., Pontoglio, M., Yaniv, M., Philipson, L., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.38.24457 · Cited by 166
Rubio-Cabezas, O., Minton, J. A. L., Kantor, I., Williams, D., Ellard, S., & Hattersley, A. T. (2010) · Diabetes · doi:10.2337/db10-0011 · Cited by 160
Levetan, C., Want, L. L., Weyer, C., Strobel, S. A., Crean, J., Wang, Y., Maggs, D. G., Kolterman, O. G., Chandran, M., Mudaliar, S. R., et al. (2003) · Diabetes Care · doi:10.2337/diacare.26.1.1 · Cited by 156
Maturity onset diabetes of the young: identification and diagnosis
McDonald, T. J., & Ellard, S. (2013) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1177/0004563213483458 · Cited by 152
Meur, G., Simon, A., Harun, N., Virally, M., Dechaume, A., Bonnefond, A., Fetita, S., Tarasov, A. I., Guillausseau, P.-J., Boesgaard, T. W., et al. (2010) · Diabetes · doi:10.2337/db09-1091 · Cited by 152
Cuesta-Muñoz, A. L., Caumo, A., Cerutti, F., Toni, S., Sulli, N., Matschinsky, F. M., Barbetti, F., Cherubini, V., Guazzarotti, L., Massa, O., et al. (2001) · Diabetologia · doi:10.1007/s001250100530 · Cited by 149
Hattersley, A., Bruining, J., Shield, J., Njolstad, P., & Donaghue, K. (2006) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2006.00217.x · Cited by 140
Steele, A. M., Wensley, K. J., Ellard, S., Murphy, R., Shepherd, M., Colclough, K., Hattersley, A. T., & Shields, B. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065326 · Cited by 133
Contrasting Diabetes Phenotypes Associated With Hepatocyte Nuclear Factor-1α and -1β Mutations
Pearson, E. R., Badman, M. K., Lockwood, C. R., Clark, P. M., Ellard, S., Bingham, C., & Hattersley, A. T. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1102 · Cited by 133
Besser, R. E. J., Shepherd, M. H., McDonald, T. J., Shields, B. M., Knight, B. A., Ellard, S., & Hattersley, A. T. (2011) · Diabetes Care · doi:10.2337/dc10-1293 · Cited by 133
Steele, A. M., Shields, B. M., Shepherd, M., Ellard, S., Hattersley, A. T., & Pearson, E. R. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02913.x · Cited by 130
Transcription factors regulating β-cell function
Cerf, M. E. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02277 · Cited by 130
Thanabalasingham, G., Shah, N., Vaxillaire, M., Hansen, T. F., Tuomilehto, J., Gašperíková, D., Szopa, M., Tjora, E., James, T. J., Kokko, P., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2261-y · Cited by 128
Harries, L. W., Ellard, S., Stride, A., Morgan, N. G., & Hattersley, A. T. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl147 · Cited by 127
Stride, A., Ellard, S., Clark, P., Shakespeare, L., Salzmann, M., Shepherd, M., & Hattersley, A. T. (2005) · Diabetes Care · doi:10.2337/diacare.28.7.1751 · Cited by 126
Randomized clinical trial of lifestyle interventions in Pima Indians: a pilot study
Venkat Narayan, K. M., Hoskin, M., Kozak, D., Kriska, A. M., Hanson, R. L., Pettitt, D. J., Nagi, D. K., Bennett, P. H., & Knowler, W. C. (1998) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(199801)15:1<66::aid-dia515>3.0.co;2-a · Cited by 123
Stoffers, D. A., Thomas, M. K., & Habener, J. F. (1997) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(97)00008-8 · Cited by 122
De novo mutations of GCK, HNF1A and HNF4A may be more frequent in MODY than previously assumed
Staník, J., Dušátková, P., Cinek, O., Valentínová, L., Hučková, M., Škopková, M., Dušátková, L., Staníková, D., Pura, M., Klimeś, I., et al. (2013) · Diabetologia · doi:10.1007/s00125-013-3119-2 · Cited by 120
Influence of maternal and fetal glucokinase mutations in gestational diabetes
Spyer, G., Hattersley, A. T., Sykes, J. E., Sturley, R., & MacLeod, K. M. (2001) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2001.113127 · Cited by 116
Owen, K. R., Thanabalasingham, G., James, T. J., Karpe, F., Farmer, A. J., McCarthy, M. I., & Gloyn, A. L. (2010) · Diabetes Care · doi:10.2337/dc10-0288 · Cited by 115
MODY in Iceland is associated with mutations in HNF -1? and a novel mutation in NeuroD1
Kristinsson, S. Y., Talseth‐Palmer, B. A., Steingrı́msson, E., Þórsson, Á. V., Helgason, T., Hreidarsson, Á. B., Thorolfsdottir, E. T., & Arngrı́msson, R. (2001) · Diabetologia · doi:10.1007/s001250100016 · Cited by 110
Fernández-Zapico, M. E., van Velkinburgh, J. C., Gutiérrez‐Aguilar, R., NEVE, B. P., Froguel, P., Urrutia, R. A., & Stein, R. W. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.028852 · Cited by 108
High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes
McDonald, T. J., Shields, B. M., Lawry, J., Owen, K. R., Gloyn, A. L., Ellard, S., & Hattersley, A. T. (2011) · Diabetes Care · doi:10.2337/dc11-0323 · Cited by 105
Johansson, B. B., Torsvik, J., Bjørkhaug, L., Vesterhus, M. N., Ragvin, A., Tjora, E., Fjeld, K., Hoem, D., Johansson, S., Ræder, H., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.222679 · Cited by 105
Møller, A. M., Dalgaard, L. T., Pociot, F., Nerup, J., Hansen, T. F., & Pedersen, O. B. (1998) · Diabetologia · doi:10.1007/s001250051101 · Cited by 101
Chen, Y., Gao, Q. C., Zhao, X., Chen, Y., Bennett, C. L., Xiong, X.-S., Mei, C., Shi, Y., & Chen, X. (2010) · PubMed · Cited by 100
Mutation in the HNF-4alpha gene affects insulin secretion and triglyceride metabolism.
Lehto, M. J., Bitzén, P. ‐., Isomaa, B., Wipemo, C., Wessman, Y., Forsblom, C. M., Tuomi, T., Taskinen, M., & Groop, L. (1999) · Diabetes · doi:10.2337/diabetes.48.2.423 · Cited by 100
Tuomi, T., Honkanen, E. H., Isomaa, B., Sarelin, L., & Groop, L. C. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1314 · Cited by 100
Roles of HNF-1β in kidney development and congenital cystic diseases
Igarashi, P., Shao, X., McNally, B. T., & Hiesberger, T. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00625.x · Cited by 99
Promoting Behavioral Science Research in Diabetes
Marrero, D. G., Peyrot, M., & Garfield, S. (2001) · Diabetes Care · doi:10.2337/diacare.24.1.1 · Cited by 97
Clinical spectrum associated with hepatocyte nuclear factor-1bêta mutations.
Bellanne-Chantelot, Chauveau, Gautier, & Dubois-Laforgue (2004) · Annals of Internal Medicine · Cited by 95
Fajans, S. S., & Brown, M. B. (1993) · Diabetes Care · doi:10.2337/diacare.16.9.1254 · Cited by 94
Who should have genetic testing for maturity‐onset diabetes of the young?
Naylor, R. N., & Philipson, L. H. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04049.x · Cited by 93
Lambert, A. P., Ellard, S., Allen, L. I. S., Gallen, I. W., Gillespie, K. M., Bingley, P. J., & Hattersley, A. T. (2003) · Diabetes Care · doi:10.2337/diacare.26.2.333 · Cited by 91
Martin, D., Bellanné‐Chantelot, C., Deschamps, I., Froguel, P., Robert, J., & Velho, G. (2008) · Diabetes Care · doi:10.2337/dc07-2017 · Cited by 85
Boesgaard, T. W., Průhová, Š., Galijatovic, E. A. A., Cinek, O., Obermannová, B., Lauenborg, J., Damm, P., Bergholdt, R., Pociot, F., Pisinger, C. H., et al. (2010) · BMC Medical Genetics · doi:10.1186/1471-2350-11-42 · Cited by 84
Maturity onset diabetes of the young and pregnancy
Colom, C., & Corcoy, R. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.05.008 · Cited by 79
The lessons of early-onset monogenic diabetes for the understanding of diabetes pathogenesis
Vaxillaire, M., Bonnefond, A., & Froguel, P. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2011.12.001 · Cited by 77
Kropff, J., Selwood, M. P., McCarthy, M. I., Farmer, A. A., & Owen, K. R. (2011) · Diabetologia · doi:10.1007/s00125-011-2090-z · Cited by 74
Role of molecular genetics in transforming diagnosis of diabetes mellitus
Molven, A., & Njølstad, P. R. (2011) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.10.123 · Cited by 66
Ledermann, H. (1995) · Diabetologia · doi:10.1007/bf00400611 · Cited by 61
Aetiological heterogeneity of asymptomatic hyperglycaemia in children and adolescents
Feigerlová, E., Průhová, Š., Dittertová, L., Lebl, J., Pintérová, D., Kološtová, K., Černá, M., Pedersen, O. B., & Hansen, T. F. (2006) · European Journal of Pediatrics · doi:10.1007/s00431-006-0106-3 · Cited by 59
Chakera, A. J., Carleton, V. L., Ellard, S., Wong, J., Yue, D. K., Pinner, J. R., Hattersley, A. T., & Ross, G. P. (2012) · Diabetes Care · doi:10.2337/dc12-0151 · Cited by 59
Clinical Heterogeneity in Monogenic Diabetes Caused by Mutations in the Glucokinase Gene (GCK-MODY)
Cuesta-Muñoz, A. L., Tuomilehto, J., Cobo‐Vuilleumier, N., Rajala, H. L. M., Odili, S., Stride, A., Buettger, C. W., Otonkoski, T., Froguel, P., Grimsby, J. S., et al. (2009) · Diabetes Care · doi:10.2337/dc09-0681 · Cited by 59
Cockburn, B. N., Bermano, G., Boodram, L.-L. G., Teelucksingh, S., Tsuchiya, T., Mahabir, D., Allan, A. B., Stein, R., Docherty, K., & Bell, G. I. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031282 · Cited by 53
Heterogeneity in young adult onset diabetes: aetiology alters clinical characteristics
Owen, K. R., Shepherd, M. H., Stride, A., Ellard, S., & Hattersley, A. T. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00766.x · Cited by 53
Fajans, S. S., Bell, G. I., Paz, V. P., Below, J. E., Cox, N. J., Martin, C., Thomas, I. H., & Chen, M. (2010) · Translational research · doi:10.1016/j.trsl.2010.03.003 · Cited by 52
Meglitinide Analogues in Adolescent Patients With HNF1A-MODY (MODY 3)
Becker, M., Galler, A., & Raile, K. (2014) · Pediatrics · doi:10.1542/peds.2012-2537 · Cited by 51
Kawasaki, E., Sera, Y., Yamakawa, K., Abe, T., Ozaki, M., Uotani, S., Ohtsu, N., Takino, H., Yamasaki, H., Yamaguchi, Y., et al. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.1.6304 · Cited by 48
Gonsorčíková, L., Průhová, Š., Cinek, O., Ek, J., Pelikánová, T., Jørgensen, T., Eiberg, H., Pedersen, O. B., Hansen, T. F., & Lebl, J. (2008) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2008.00379.x · Cited by 47
Bacon, S., Kyithar, M. P., Schmid, J., Rizvi, S. R., Bonner, C., Graf, R., Prehn, J. H. M., & Byrne, M. M. (2012) · BMC Endocrine Disorders · doi:10.1186/1472-6823-12-13 · Cited by 47
Bonnefond, A., Yengo, L., Philippe, J., Dechaume, A., Ezzidi, I., Vaillant, E., Gjesing, A. P., Galijatovic, E. A. A., Czernichow, S., Herçberg, S., et al. (2012) · Diabetologia · doi:10.1007/s00125-012-2794-8 · Cited by 46
Crow, J. F., & Kimura, M. (1972) · Europe PMC (PubMed Central) · Cited by 43
Raile, K., O’Connell, M. A., Galler, A., Werther, G. A., Kühnen, P., Krude, H., & Blankenstein, O. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0208 · Cited by 43
Monogenic diabetes in children and young adults: Challenges for researcher, clinician and patient
Slingerland, A. S. (2006) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-006-9014-0 · Cited by 42
Galán, M., García-Herrero, C.-M., Azriel, S., Gargallo, M., Durán, M., Gorgojo, J.-J., Andía, V.-M., & Navas, M.-A. (2011) · Molecular Medicine · doi:10.2119/molmed.2010.00097 · Cited by 37
Besser, R. E., Shields, B. M., Hammersley, S. E., Colclough, K., McDonald, T. J., Gray, Z., Heywood, J. J., Barrett, T. G., & Hattersley, A. T. (2012) · Pediatric Diabetes · doi:10.1111/pedi.12008 · Cited by 36
Docena, M. K., Faiman, C., Stanley, C. M., & Pantalone, K. M. (2013) · Endocrine Practice · doi:10.4158/ep13254.or · Cited by 31
Bowden, S. A., & Hoffman, R. P. (2008) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2007.00335.x · Cited by 29
Ethel Codner, D., Rocha, A., Deng, L., Martínez‐Aguayo, A., Godoy, C., Verónica Mericq, G., & Chung, W. K. (2009) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2009.00499.x · Cited by 28
Borg, H., Marcus, C. Z., Sjöblad, S., Fernlund, P., & Sundkvist, G. (2002) · Pediatric Diabetes · doi:10.1034/j.1399-5448.2002.30305.x · Cited by 27
Edghill, E. L., Flanagan, S., Patch, A., Boustred, C., Parrish, A., Shields, B., Shepherd, M., Hussain, K., Kapoor, R. R., Malecki, M., et al. (2008) · UCL Discovery (University College London) · Cited by 19
The coexistence of type 1 diabetes, MODY2 and metabolic syndrome in a young girl
Calcaterra, V., Martinetti, M., Salina, A., Aloi, C., & Larizza, D. (2011) · Acta Diabetologica · doi:10.1007/s00592-011-0300-2 · Cited by 16
Adolescent onset Type 2 diabetes in a non‐obese Caucasian patient with an unbalanced translocation
Owen, K. R., Roland, J., Smith, K., & Hattersley, A. T. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00961.x · Cited by 12
Severe Hypophosphatemic Osteomalacia Secondary to Fanconi Syndrome Due to Adefovir: A Case Report
Palermo, A., Strollo, R., Papalia, R., D’Onofrio, L., Maddaloni, E., Briganti, S., Napoli, N., Gentilucci, U. V., Costantino, S., Pozzilli, P., et al. (2014) · Endocrine Practice · doi:10.4158/ep14251.cr · Cited by 11
Urbanová, J., Rypáčková, B., Kučera, P., Anděl, M., & Heneberg, P. (2013) · International Archives of Allergy and Immunology · doi:10.1159/000346906 · Cited by 10
Stride, A., Ellard, S., Clark, P., Shakespeare, L., Salzmann, M. B., Shepherd, M., & Hattersley, A. T. (2005) · Royal Devon and Exeter Research Repository (Royal Devon and Exeter) · Cited by 8
Research works printed but not linked: 93
- McDonald, 2011, High - sensitivity CRP discriminates from other subtypes of diabetes, Diabetes Care, 10.2337/dc11-0323 · DOI · Paper page
- Spyer, 2001, AT KM Influence of maternal and fetal glucokinase mutations in gestational diabetes, Am J Obstet Gynecol, 185
- Hattersley, 1998, AT Maturity - onset diabetes of the young : clinical heterogeneity explained by genetic heterogeneity, Med, 15, 15
- Chakera, 2012, Antenatal diagnosis of fetal genotype determines if maternal hyperglycemia due to a glucokinase mutation requires treatment, Diabetes Care, 10.2337/dc12-0151 · DOI
- Borowiec, 2009, Mutations at the BLK locus linked to maturity onset diabetes of the young and beta - cell dysfunction, Proc Natl Acad Sci USA, 106
- Fajans, 1993, MB Administration of sulfonylureas can increase glucose - induced insulin secretion for decades in patients with maturity - onset diabetes of the young, Diabetes Care, 16, 10.2337/diacare.16.9.1254 · DOI · Paper page
- Colom, 2010, Maturity onset diabetes of the young and pregnancy, Pract Res Clin Endocrinol Metab, 24, 605, 10.1016/j.beem.2010.05.008 · DOI
- Cerf, 2006, ME factors regulating beta function, Transcription cell Eur J Endocrinol, 155
- Schober, 2009, Phenotypical aspects of maturity - onset diabetes of the young diabetes in comparison with Type diabetes mellitus DM in children and adolescents : experience from a large multicentre database, Med, 26, 466
- Stanik, 2014, De novo mutations of may be more frequent in MODY than previously assumed, Diabetologia, 1
- Molven, 2011, PR Role of molecular genetics in transforming diagnosis of diabetes mellitus, Expert Rev Mol Diagn, 11, 313, 10.1586/erm.10.123 · DOI · Paper page
- Becker, 2014, analogues in adolescent patients with, Pediatrics, 1
- Massa, 2001, High prevalence of glucokinase mutations in Italian children with MODY Influence on glucose tolerance first - phase insulin response insulin sensitivity and BMI, Diabetologia, 898
- Pearson, 2004, Contrasting diabetes phenotypes associated with hepatocyte nuclear factor alpha and beta mutations, Diabetes Care, 27, 1, 10.2337/diacare.27.5.1102 · DOI · Paper page
- Owen, 2002, AT Heterogeneity in young adult onset diabetes : aetiology alters clinical characteristics, Med, 19, 758
- Calcaterra, 2012, The coexistence of Type diabetes metabolic syndrome in a young girl, Acta Diabetol, 49
- Chen, 2010, Systematic review of anomalies in renal cysts and diabetes syndrome / maturity onset diabetes of the young type, Med Engl, 123
- Urbanova, 2013, Should the negativity for islet cell autoantibodies be used in a prescreening for genetic testing in maturity - onset diabetes of the young ? The case of autoimmunity - associated destruction of pancreatic beta - cells in a family of HNF MODY subjects, Int Arch Allergy, 1
- Stanik, 2014, De novo mutations of may be more frequent in MODY than previously assumed, Diabetologia, 1
- Kristinsson, 2001, in Iceland is associated with mutations in alpha and a novel mutation in, Diabetologia, 1
- Wang, 2004, The concerted activities of are essential to initiate pancreatic beta - cell differentiation, Dev Biol, 266
- Pontoglio, 2000, alpha controls renal glucose reabsorption in mouse and man, EMBO Rep, 1
- Osbak, 2009, Update on mutations in glucokinase which cause maturity - onset diabetes of the young permanent neonatal diabetes and hyperinsulinemic hypoglycemia, Hum Mutat, 30, 10.1002/humu.21110 · DOI · Paper page
- Becker, 2014, analogues in adolescent patients with, Pediatrics, 1
- Bonnefond, 2013, Reassessment of the putative role of loss - of - function mutation in Type diabetes, Diabetologia, 71
- Naylor, 2011, Who should have genetic testing for maturity - onset diabetes of the young, Clin Endocrinol, 422, 10.1111/j.1365-2265.2011.04049.x · DOI
- Borg, 2002, Insulin autoantibodies are of less value compared with islet antibodies in the clinical diagnosis of autoimmune Type diabetes in children older than yr of age, Pediatr Diabetes, 1
- Stoffers, 1997, DA Early - onset Type - II diabetes mellitus linked to, Nat Genet, 17, 1
- Plengvidhya, 2007, mutations in Thais with maturity onset diabetes of the young, J Clin Endocrinol Metab, 2821, 10.1210/jc.2006-1927 · DOI · Paper page
- Fajans, 2010, and hyperinsulinemia in a family with pancreatic agenesis and MODY caused by the mutation Pro fsX, Obesity Transl Res, 63, 1
- Feigerlova, 2006, Aetiological heterogeneity of asymptomatic hyperglycaemia in children and adolescents, Eur J Pediatr, 165
- Kropff, 2011, Prevalence of monogenic diabetes in young adults : a community - based cross - sectional study in Oxfordshire UK, Diabetologia, 10.1007/s00125-011-2090-z · DOI
- Vaxillaire, 2012, The lessons of early - onset monogenic diabetes for the understanding of diabetes pathogenesis, Pract Res Clin Endocrinol Metab, 26, 171, 10.1016/j.beem.2011.12.001 · DOI
- Pearson, 2003, Genetic cause of hyperglycaemia and response to treatment in diabetes, Lancet, 362
- Wang, 2004, The concerted activities of are essential to initiate pancreatic beta - cell differentiation, Dev Biol, 266
- Tattersall, 1975, SS difference between the inheritance of classical juvenile - onset and maturity - onset type diabetes of young people, Diabetes, 24
- Raile, 2011, caused by insulin gene INS deletion clinical characteristics of homozygous and heterozygous individuals, Diabetes Eur J Endocrinol, 165
- McDonald, 2011, Islet autoantibodies can discriminate maturity - onset diabetes of the young from Type diabetes, Med, 28, 1
- Frayling, 1997, Mutations in the hepatocyte nuclear factor - alpha gene are a common cause of maturity - onset diabetes of the young in the, Diabetes, 1
- Pearson, 2007, and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the gene, PLoS Med, 10.1371/journal.pmed.0040118 · DOI · Paper page
- Pearson, 2005, Molecular genetics and phenotypic characteristics of MODY caused by hepatocyte nuclear factor alpha mutations in a large European collection, Diabetologia, 4
- McDonald, 2013, Maturity onset diabetes of the young identification diagnosis, Ann Clin Biochem, 15, 403, 10.1177/0004563213483458 · DOI · Paper page
- MODY, 1995, Ledermann HM Maturity - onset diabetes of the young at least ten times more common in Europe than previously assumed, Diabetologia
- Harries, 2006, AT of the TCF gene encoding hepatocyte nuclear factor - alpha show differential expression in the pancreas and define the relationship between mutation position and clinical phenotype in monogenic diabetes, Hum Mol Genet, 15, 1, 10.1093/hmg/ddl147 · DOI · Paper page
- Tattersall, 1974, Mild familial diabetes with dominant inheritance, J Med, 339
- Schwitzgebel, 2003, Agenesis of human pancreas due to decreased half - life of insulin promoter factor, J Clin Endocrinol Metab, 1
- Sera, 2000, Kawasaki Identification and functional analysis of mutations in the hepatocyte nuclear factor - alpha gene in anti - islet autoantibody - negative Japanese patients with Type diabetes, J Clin Endocrinol Metab, 1
- Bingham, 2001, Mutations in the hepatocyte nuclear factor beta gene are associated with familial hypoplastic glomerulocystic kidney disease, Am J Hum Genet, 24, 1
- Stride, 2002, The genetic abnormality in the beta cell determines the response to an oral glucose load, Diabetologia, 427, 10.1007/s00125-001-0770-9 · DOI · Paper page
- Lambert, 2003, Identifying hepatic nuclear factor alpha mutations in children and young adults with a clinical diagnosis of Type diabetes, Diabetes Care, 26, 1, 10.2337/diacare.26.2.333 · DOI · Paper page
- Edghill, 2006, AT Mutations in hepatocyte nuclear factor beta and their related phenotypes, J Med Genet, 1
- Bowden, 2008, Triple diabetes : coexistence of Type diabetes mellitus and a novel mutation in the gene responsible for MODY in an overweight adolescent, Pediatr Diabetes, 1
- Tuomi, 2006, Improved prandial glucose control with lower risk of hypoglycemia with nateglinide than with glibenclamide in patients with maturity - onset diabetes of the young type, Diabetes Care, 29, 189, 10.2337/diacare.29.02.06.dc05-1314 · DOI · Paper page
- Habener, 2005, transcriptional regulation in pancreatic development, Endocrinology, 146
- Leslie, 1999, GAD in Type insulin dependent diabetes, Diabetologia, 42, 10.1007/s001250051105 · DOI · Paper page
- Cuesta, 2010, Clinical heterogeneity in monogenic diabetes caused by mutations in the glucokinase gene, Diabetes Care, 290, 10.2337/dc09-0681 · DOI
- Shepherd, 2009, AT genetic diagnosis of diabetes alters treatment and improves glycaemic control in the majority of insulin - treated patients, Med, 26, 1
- Velho, 1997, Identification of new glucokinase mutations and description of the clinical profile of families, Diabetologia, 14, 217, 10.1007/s001250050666 · DOI · Paper page
- Bonnefond, 2013, Reassessment of the putative role of loss - of - function mutation in Type diabetes, Diabetologia, 71
- Steele, 2013, Use of in the identification of patients with hyperglycaemia caused by a glucokinase mutation : observational case control studies One, AM, 1
- Kristinsson, 2001, in Iceland is associated with mutations in alpha and a novel mutation in, Diabetologia, 1
- Boesgaard, 2010, Further evidence that mutations in INS can be a rare cause of maturity - onset diabetes of the young, BMC Med Genet, 11
- Besser, 2011, RE Urinary - peptide creatinine ratio is a practical outpatient tool for identifying hepatocyte nuclear factor alpha hepatocyte nuclear factor alpha maturity - onset diabetes of the young from long - duration Type diabetes, Diabetes Care, 1
- Colclough, 2013, Mutations in the genes encoding the transcription factors hepatocyte nuclear factor alpha alpha in maturity - onset diabetes of the young and hyperinsulinemic hypoglycemia, Hum Mutat, 1
- Molven, 2008, Mutations in the insulin gene can cause MODY and autoantibody - negative Type diabetes, Diabetes, 1
- Fajans, 2001, SS GI Molecular mechanisms and clinical pathophysiology of maturity - onset diabetes of the young, New Engl J Med, 345
- Edghill, 2006, Hepatocyte nuclear factor beta mutations cause neonatal diabetes and intrauterine growth retardation : support for a critical role of HNF beta in human pancreatic development, Med, 23, 1
- Ulinski, 2006, Renal phenotypes related to hepatocyte nuclear factor beta mutations in a pediatric cohort, J Am Soc Nephrol, 17, 497, 10.1681/asn.2005101040 · DOI · Paper page
- Galan, 2011, Differential effects of HNF alpha mutations associated with familial young - onset diabetes on target gene regulation, Mol Med, 17, 1, 10.2119/molmed.2010.00097 · DOI · Paper page
- Calcaterra, 2012, The coexistence of Type diabetes metabolic syndrome in a young girl, Acta Diabetol, 49
- Rubio, 2010, Homozygous mutations in are responsible for a novel syndrome of permanent neonatal diabetes and neurological abnormalities, Diabetes, 31, 1
- Neve, 2005, Role of transcription factor and its diabetes - associated gene variants in pancreatic beta cell function, Proc Natl Acad Sci USA, 11, 4807, 10.1073/pnas.0409177102 · DOI · Paper page
- Owen, 2010, Assessment of high - sensitivity reactive protein levels as diagnostic discriminator of maturity - onset diabetes of the young due to mutations, Diabetes Care, 24, 1
- Stoffers, 1997, DA Early - onset Type - II diabetes mellitus linked to, Nat Genet, 17, 1
- Lehto, 1999, Mutation in the HNF alpha gene affects insulin secretion and triglyceride metabolism, Diabetes, 5, 423, 10.2337/diabetes.48.2.423 · DOI
- Raeder, 2006, PI IS Mas Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction, Nat Genet, 38
- Stride, 2014, Cross - sectional and longitudinal studies suggest pharmacological treatment used in patients with glucokinase mutations does not alter glycaemia, Diabetologia, 57, 54, 10.1007/s00125-013-3075-x · DOI · Paper page
- Owen, 2003, AT Adolescent onset Type diabetes in a non - obese Caucasian patient with an unbalanced translocation, Med, 20, 483
- Owen, 2011, Thanabalasingham Diagnosis and management of maturity onset diabetes of the young, Brit Med J, 343
- Stoffel, 1997, The maturity - onset diabetes of the young transcription factor alpha regulates expression of genes required for glucose transport and metabolism, Proc Natl Acad Sci USA, 14, 1
- Fajans, 2011, GI genetics pathophysiology clinical decision making, history Diabetes Care, 10.2337/dc11-0035 · DOI · Paper page
- Meur, 2010, Insulin gene mutations resulting in early - onset diabetes : marked differences in clinical presentation metabolic status and pathogenic effect through endoplasmic reticulum retention, Diabetes, 59
- Pihoker, 2013, Prevalence characteristics and clinical diagnosis of maturity onset diabetes of the young due to mutations in glucokinase : results from the SEARCH for Diabetes in Youth, J Clin Endocrinol Metab, 1
- Horikawa, 1997, Mutation in hepatocyte nuclear factor beta gene associated with, Nat Genet, 17, 384, 10.1038/ng1297-384 · DOI · Paper page
- Martin, 2008, Long - term follow - up of oral glucose tolerance test - derived glucose tolerance and insulin secretion and insulin sensitivity indexes in subjects with glucokinase mutations, Diabetes Care, 31, 10.2337/dc07-2017 · DOI
- Shields, 2012, The development and validation of a clinical prediction model to determine the probability of MODY in patients with young - onset diabetes, Diabetologia, 10.1007/s00125-011-2418-8 · DOI · Paper page
- Docena, 2014, KM novel mutation and the utility of glucagon - like peptide receptor agonist therapy, Endocr Pract, 20, 1, 10.4158/ep13254.or · DOI
- Moller, 1998, Mutations in the hepatocyte nuclear factor - alpha gene in Caucasian families originally classified as having Type I diabetes, AM Diabetologia, 31, 1
- Slingerland, 2006, AS diabetes in children and young adults : challenges for researcher clinician patient, Rev, 171
- Dukes, 1998, ID Defective pancreatic beta - cell glycolytic signaling in hepatocyte nuclear factor alpha - deficient mice, J Biol Chem, 1
- Steele, 2010, AT Increased all - cause and cardiovascular mortality in monogenic diabetes as a result of mutations in the gene, AM Med, 27, 1
- Igarashi, 2005, Roles of beta in kidney development and congenital cystic diseases, Kidney Int, 1
- Gonsorcikova, 2008, Autosomal inheritance of diabetes in two families characterized by obesity and a novel mutation in, Pediatr Diabetes, 241
Cited by
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s002 · Cited by 4,792
2. Classification and Diagnosis of Diabetes:Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Gaglia, J. L., Hilliard, M. E., Isaacs, D., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s002 · Cited by 2,433
2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Gaglia, J. L., Hilliard, M. E., Johnson, E. L., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s002 · Cited by 2,086
O’Sullivan, J. W., Raghavan, S., Marquez-Luna, C., Luzum, J. A., Damrauer, S. M., Ashley, E. A., O’Donnell, C. J., Willer, C. J., Natarajan, P., & on behalf of the American Heart Association Council on Genomic and Precision Medicine; Council on Clinical Cardiology; Council on Arteriosclerosis, T. A. V. B. C. O. C. R. A. I. C. O. L. A. C. H. A. C. O. P. V. D. (2022) · Circulation · doi:10.1161/cir.0000000000001077 · Cited by 412
Schwartz, S. S., Epstein, S., Corkey, B. E., Grant, S. F. A., Gavin, J. R., & Aguilar, R. B. (2016) · Diabetes Care · doi:10.2337/dc15-1585 · Cited by 329
Metadata
- Authors
- Anık, A., Çatlı, G., Abacı, A., & Böber, E.
- Affiliations
- Dokuz Eylül University (TR)
- Corresponding author
- Abacı, Ayhan
- Venue
- Journal of Pediatric Endocrinology and Metabolism
- Publisher
- Walter de Gruyter GmbH
- Published
- 2015-01-01
- Volume
- 28
- Issue
- 3-4
- Pages
- 251-63
- ISSN
- 0334-018X (ISSN-L)
- 2191-0251
- OpenAlex
- W1986614590
- Cited by
- 198
- References
- 118
- Citations by year
- 2026: 2 · 2025: 13 · 2024: 15 · 2023: 17 · 2022: 36 · 2021: 28 · 2020: 29 · 2019: 25 · 2018: 17 · 2017: 8 · 2016: 7 · 2015: 1
- FWCI
- 2.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Pediatric Endocrinology and Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- maturity-onset diabetes of the young, monogenic diabetes, HNF1A mutations, HNF4A mutations, HNF1B mutations, beta-cell dysfunction, pancreatic agenesis, sulfonylurea therapy, ATP-sensitive potassium channels, molecular diagnosis, fasting hyperglycemia, microvascular complications
- MeSH terms
- Adult, Diabetes Mellitus, Type 2, Glucokinase, Humans, Mutation, Sulfonylurea Compounds, Prevalence, Hepatocyte Nuclear Factor 1-alpha, Hepatocyte Nuclear Factor 4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.